0001209191-19-025841.txt : 20190424
0001209191-19-025841.hdr.sgml : 20190424
20190424202556
ACCESSION NUMBER: 0001209191-19-025841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190422
FILED AS OF DATE: 20190424
DATE AS OF CHANGE: 20190424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrett John A
CENTRAL INDEX KEY: 0001388395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 19765056
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE, SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-22
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0001388395
Barrett John A
C/O PHIO PHARMACEUTICALS CORP.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
0
1
0
0
Chief Development Officer
Common stock, $0.0001 par value
2019-04-22
4
A
0
222991
0.00
A
222991
D
This amount is comprised entirely of Restricted Stock Units which shall vest in equal installments over four years, with the first installment on April 22, 2020 and the last installment on April 22, 2023, subject to continued employment with the Company on the applicable vesting date.
Caitlin Kontulis, attorney-in-fact
2019-04-24